Want to see BBOT full AI Analyst Report?
BridgeBio Oncology Therapeutics (BBOT) Ownership Overview
40.70% Insiders
3.36% Mutual Funds
7.65% Other Institutional Investors
4.41% ETFs
43.89% Public Companies and
Individual Investors
The ownership structure of BridgeBio Oncology Therapeutics (BBOT) stock is a mix of institutional, retail, and individual investors. Approximately 15.42% of the company’s stock is owned by Institutional Investors, 40.70% is owned by Insiders, and 43.89% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $2933250 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 17,878,594 | Insider | 22.30% | 164,125,493 | |
| 14,589,846 | Insider | 18.20% | 133,934,786 | |
| 4,885,446 | Institution | 6.09% | 44,848,394 | |
| 3,289,661 | Institution | 4.10% | 30,199,088 | |
| 1,973,532 | Institution | 2.46% | 18,117,024 | |
| 1,018,018 | Institution | 1.27% | 9,345,405 | |
| 862,482 | Institution | 1.08% | 7,917,585 | |
| 673,766 | Institution | 0.84% | 6,185,172 | |
| 538,049 | Institution | 0.67% | 4,939,290 | |
| 502,631 | Institution | 0.63% | 4,614,153 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 673,766 | Institution | 0.84% | 6,185,172 | |
| 538,049 | Institution | 0.67% | 4,939,290 | |
| 502,631 | Institution | 0.63% | 4,614,153 | |
| 333,485 | Institution | 0.42% | 3,061,392 | |
| 249,513 | Institution | 0.31% | 2,290,529 | |
| 240,300 | Institution | 0.30% | 2,205,954 | |
| 83,182 | Institution | 0.10% | 763,611 | |
| 32,000 | Institution | 0.04% | 293,760 | |
| 22,007 | Institution | 0.03% | 202,024 | |
| 9,785 | Institution | 0.01% | 89,826 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,422,900 | Institution | 1.77% | 11,511,261 | |
| 877,782 | Institution | 1.09% | 8,128,261 | |
| 550,632 | Institution | 0.69% | 4,454,613 | |
| 321,384 | Institution | 0.40% | 2,950,305 | |
| 225,290 | Institution | 0.28% | 2,086,185 | |
| 96,950 | Institution | 0.12% | 897,757 | |
| 40,107 | Institution | 0.05% | 368,182 | |
| 27,500 | Institution | 0.03% | 254,650 | |
| 12,553 | Institution | 0.02% | 115,237 | |
| 378 | Institution | <0.01% | 3,500 |
FAQ
Who Owns BridgeBio Oncology Therapeutics (BBOT)?
According to the latest TipRanks data, approximately 7.65% of the company's stock is held by institutional investors, 40.70% is held by insiders, and 43.89% is held by retail investors.
What percentage of BridgeBio Oncology Therapeutics (BBOT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.65% of BridgeBio Oncology Therapeutics (BBOT) stock is held by institutional investors.
What percentage of BridgeBio Oncology Therapeutics (BBOT) stock is held by retail investors?
According to the latest TipRanks data, approximately 43.89% of BridgeBio Oncology Therapeutics (BBOT) stock is held by retail investors.
Who owns the most shares of BridgeBio Oncology Therapeutics (BBOT)?
Bihua Chen owns the most shares of BridgeBio Oncology Therapeutics (BBOT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.